Portfolio company
Immunicon Corporation
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops cell-based diagnostic tools and cancer detection kits for clinical researchers and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Epigenomics
This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Veracyte
This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.
Limosa Immunodiagnostics
This company develops diagnostic tests for latent tuberculosis and other immune-related diseases for patients and healthcare providers.
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
Bio-Techne Corporation
This company manufactures life science reagents, analytical instruments and precision diagnostics for academic researchers, biopharmaceutical companies and clinical diagnostic laboratories.
Biome Diagnostics
This company develops AI-powered microbiome diagnostic tools and cancer immunotherapy prediction tests for healthcare professionals, laboratories, and individual consumers.
Genomic Vision
This company develops molecular combing technology and DNA analysis tools for researchers and clinicians in diagnostic and drug discovery sectors.
